Skip to content

Pentosan Polysulfate

A semi-synthetic polysaccharide with FDA approval for interstitial cystitis, also studied for joint and cartilage health.

StrongWell-Studied

Always consult a qualified clinician

This information is for educational purposes. Peptide therapy should be guided by a licensed healthcare provider. Connect with a Noho clinician

What is Pentosan Polysulfate?

Pentosan Polysulfate (PPS) is a semi-synthetic heparin-like compound derived from beechwood. It is FDA-approved (as Elmiron) for the treatment of interstitial cystitis (painful bladder syndrome). It is also approved in veterinary medicine (as Cartrophen) for osteoarthritis in dogs. It is discussed in the peptide space for its potential joint and cartilage health benefits.

Why People Talk About It

Joint and cartilage support

Moderate

Interstitial cystitis (FDA-approved)

Strong

Anti-inflammatory effects

Moderate

How It Works

PPS works by coating and protecting damaged tissue surfaces, reducing inflammation, and potentially supporting cartilage repair. In the bladder, it helps restore the protective lining. In joints, it may support the health of cartilage and synovial fluid.

Common Questions

Safety Information

Important Safety Notes

Common Side Effects

GI upsetHeadacheHair loss (rare)Potential retinal changes with long-term oral use

Cautions

  • FDA warning about pigmentary maculopathy with long-term oral use
  • Regular eye exams recommended for long-term users
  • May increase bleeding risk

What We Don't Know

The mechanism of retinal toxicity is not fully understood. Risk factors for developing maculopathy are being studied.

Published Research

32 studies

Risk and Dose-Response Relationship for Pentosan Polysulfate Sodium Maculopathy: A Systematic Review and Meta-Analysis

Meta-AnalysisPMID: 40074062

Efficacy of different treatment strategies in patients with mucopolysaccharidosis: a systematic review and network meta-analysis of randomized controlled trials

Meta-AnalysisPMID: 40317013

[Protective properties of urothelium and possibilities of targeted pathogenetic therapy of chronic pelvic pain: sodium pentosan polysulfate]

Meta-AnalysisPMID: 36098600

Efficacy and safety comparison of pharmacotherapies for interstitial cystitis and bladder pain syndrome: a systematic review and Bayesian network meta-analysis

Meta-AnalysisPMID: 33638677

Interventions for treating people with symptoms of bladder pain syndrome: a network meta-analysis

Meta-AnalysisPMID: 32734597

Intravesical treatment for interstitial cystitis/painful bladder syndrome: a network meta-analysis

Meta-AnalysisPMID: 27614759

Contemporary management of the painful bladder: a systematic review

Meta-AnalysisPMID: 21920661

The risk for cross-reactions after a cutaneous delayed-type hypersensitivity reaction to heparin preparations is independent of their molecular weight: a systematic review

Meta-AnalysisPMID: 21631519

Efficacy of pentosan polysulfate in the treatment of interstitial cystitis: a meta-analysis

Meta-AnalysisPMID: 9218016

Pentosan Polysulfate Maculopathy: What Urologists Should Know in 2020

Systematic ReviewPMID: 33045286

Efficacy of pentosan polysulfate for the treatment of interstitial cystitis/bladder pain syndrome: results of a systematic review of randomized controlled trials

Systematic ReviewPMID: 30849922

A single-center, phase 1/2a trial of hESC-derived mesenchymal stem cells (MR-MC-01) for safety and efficacy in interstitial cystitis patients

Randomized Controlled TrialPMID: 40387787

A post-trial follow-up study of pentosan polysulfate monotherapy on preventing recurrent urinary tract infection in women

Randomized Controlled TrialPMID: 36202908

Pentosan polysulfate sodium for Ross River virus-induced arthralgia: a phase 2a, randomized, double-blind, placebo-controlled study

Randomized Controlled TrialPMID: 33711991

The efficacy of pentosan polysulfate monotherapy for preventing recurrent urinary tract infections in women: A multicenter open-label randomized controlled trial

Randomized Controlled TrialPMID: 31813658

Sodium pentosan polysulfate efficacy as thromboprophylaxis agent in high-risk women following gynecological surgery

Randomized Controlled TrialPMID: 29845672

Efficacy of intravesical pentosan polysulfate sodium in cats with obstructive feline idiopathic cystitis

Randomized Controlled TrialPMID: 26116618

Treatment of experimentally induced osteoarthritis in horses using an intravenous combination of sodium pentosan polysulfate, N-acetyl glucosamine, and sodium hyaluronan

Randomized Controlled TrialPMID: 24819506

Effects of intra-articular sodium pentosan polysulfate and glucosamine on the cytology, total protein concentration and viscosity of synovial fluid in horses

Randomized Controlled TrialPMID: 22827626

A potent oral P-selectin blocking agent improves microcirculatory blood flow and a marker of endothelial cell injury in patients with sickle cell disease

Randomized Controlled TrialPMID: 22488107

The relationship among symptoms, sleep disturbances and quality of life in patients with interstitial cystitis

Randomized Controlled TrialPMID: 19375108

Evaluation of health-related quality of life in patients with painful bladder syndrome/interstitial cystitis and the impact of four treatments on it

Randomized Controlled TrialPMID: 19137459

Association between response to pentosan polysulfate sodium therapy for interstitial cystitis and patient questionnaire-based treatment satisfaction

Randomized Controlled TrialPMID: 18582395

Safety and efficacy of the use of intravesical and oral pentosan polysulfate sodium for interstitial cystitis: a randomized double-blind clinical trial

Randomized Controlled TrialPMID: 18001798

Urinary epidermal growth factor and interleukin-6 levels in patients with painful bladder syndrome/interstitial cystitis treated with cyclosporine or pentosan polysulfate sodium

Randomized Controlled TrialPMID: 18387391

Time to initiation of pentosan polysulfate sodium treatment after interstitial cystitis diagnosis: effect on symptom improvement

Randomized Controlled TrialPMID: 18242365

Evaluation of pentosan polysulfate sodium in the postoperative recovery from cranial cruciate injury in dogs: a randomized, placebo-controlled clinical trial

Randomized Controlled TrialPMID: 17461948

Potassium sensitivity test (PST) as a measurement of treatment efficacy of painful bladder syndrome/interstitial cystitis: a prospective study with cyclosporine A and pentosan polysulfate sodium

Randomized Controlled TrialPMID: 17078084

Cyclosporine A and pentosan polysulfate sodium for the treatment of interstitial cystitis: a randomized comparative study

Randomized Controlled TrialPMID: 16280777

Pentosan polysulfate sodium for treatment of interstitial cystitis/bladder pain syndrome: insights from a randomized, double-blind, placebo controlled study

Randomized Controlled TrialPMID: 25245489

Efficacy of Pentosan Polysulfate Treatment in Patients with Interstitial Cystitis/Bladder Pain Syndrome

Clinical TrialPMID: 37936582

Pentosan polysulfate: a review of its use in the relief of bladder pain or discomfort in interstitial cystitis

ReviewPMID: 16706553

Always consult a qualified clinician

This information is for educational purposes. Peptide therapy should be guided by a licensed healthcare provider. Connect with a Noho clinician

Related Peptides

Quick Facts

Class
Polysaccharide
Evidence
Strong
Safety
Well-Studied
Updated
Feb 2026
Citations
32PubMed

Also known as

PPSElmironCartrophen

Tags

Joint HealthFDA-ApprovedCartilageAnti-Inflammatory

Related Goals

Evidence Score

Overall Confidence72%

Clinical Trials

View Clinical Trials

Links to ClinicalTrials.gov for reference. Listing does not imply endorsement.

Clinician Guided

Interested in this peptide? A Noho clinician can help determine if it's right for you.

Talk to a Clinician